---

Evidence for immunothrombosis according to some markers of thromboinflammation in women with unexplained recurrent reproductive failures

Full Text PDF Share on Facebook Share on Twitter

---

Original Article

Author Details : Alphonsus Ogbonna Ogbuabor*

Volume : 2, Issue : 2, Year : 2023

Article Page : 95-98

Suggest article by email

Abstract

Background: Unexplained recurrent reproductive failures (URRF) is a term that describes three different conditions of infertility, namely unexplained infertility (UI), unexplained recurrent miscarriage,and unexplained recurrent implantation failures. It is a global reproductive health problem. The aim of the present study was to compare some systemic markers of thromboinflammation in women with URRF to controls.

Materials and Methods: This was a case–control study involving 70 subjects (35 cases of URRF and 35 healthy control women). The systemic cellular markers of immunothrombosis involving the platelet count, mean platelet volume (MPV), platelet distribution width (PDW), plateletcrit (PCT), neutrophil-to-lymphocyte ratio (NLR), and the platelet-to-lymphocyte ratio were determined using the Sysmex XN-10 Automated Hematology Analyzer, Sysmex Corporations Japan. Data were analyzed using one-way analysis of variance in GraphPad Prism version 8.0 (GraphPad Software, San Diego, CA, USA) and presented as mean±standard deviation. Statistical significance was defined as p<0>

Results: The MPV, PDW, and NLR were significantly increased (p=0.002, 0.007, and 0.028), respectively, in the subjects with URRF compared to the healthy controls. Conclusion: This finding supports evidence for immunothrombosis in patients with URRF.

Keywords: Low-grade chronic inflammation, Low-grade intravascular coagulation, Unexplained infertility, Unexplained recurrent implantation failures, Unexplained recurrent miscarriage

How to cite : Ogbuabor A O, Evidence for immunothrombosis according to some markers of thromboinflammation in women with unexplained recurrent reproductive failures. Yemen J Med 2023;2(2):95-98

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International, which allows others to remix, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.